|
1
|
Gil-Campos M, Cañete RR and Gil A:
Adiponectin, the missing link in insulin resistance and obesity.
Clin Nutr. 23:963–974. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ukkola O and Santaniemi M: Adiponectin: a
link between excess adiposity and associated comorbidities? J Mol
Med (Berl). 80:696–702. 2002. View Article : Google Scholar
|
|
3
|
Yamauchi T, Kamon J, Waki H, et al: The
fat-derived hormone adiponectin reverses insulin resistance
associated with both lipoatrophy and obesity. Nat Med. 7:941–946.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kadowaki T, Yamauchi T, Kubota N, et al:
Adiponectin and adiponectin receptors in insulin resistance,
diabetes, and the metabolic syndrome. J Clin Invest. 116:1784–1792.
2006. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Maeda N, Shimomura I, Kishida K, et al:
Diet-induced insulin resistance in mice lacking adiponectin/ACRP30.
Nat Med. 8:731–737. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li S, Shin HJ, Ding EL, et al: Adiponectin
levels and risk of type 2 diabetes: a systematic review and
meta-analysis. JAMA. 302:179–188. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yamauchi T and Kadowaki T: Adiponectin
receptor as a key player in healthy longevity and obesity-related
diseases. Cell Metab. 17:185–196. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fernández-Hernando C, Ramírez CM, Goedeke
L and Suárez Y: MicroRNAs in metabolic disease. Arterioscler Thromb
Vasc Biol. 33:178–185. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Poy MN, Eliasson L, Krutzfeldt J, et al: A
pancreatic islet-specific microRNA regulates insulin secretion.
Nature. 432:226–230. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Frost RJ and Olson EN: Control of glucose
homeostasis and insulin sensitivity by the Let-7 family of
microRNAs. Proc Natl Acad Sci USA. 108:21075–21080. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhu H, Shyh-Chang N, Segrè AV, et al: The
Lin28/let-7 axis regulates glucose metabolism. Cell. 147:81–94.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Trajkovski M, Hausser J, Soutschek J, et
al: MicroRNAs 103 and 107 regulate insulin sensitivity. Nature.
474:649–653. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pullen TJ, da Silva Xavier G, Kelsey G and
Rutter GA: miR-29a and miR-29b contribute to pancreatic
beta-cell-specific silencing of monocarboxylate transporter 1
(Mct1). Mol Cell Biol. 31:3182–3194. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gao X, Dong H, Lin C, et al: Reduction of
AUF1-mediated follistatin mRNA decay during glucose starvation
protects cells from apoptosis. Nucleic Acids Res. 42:10720–10730.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Debard C, Laville M, Berbe V, et al:
Expression of key genes of fatty acid oxidation, including
adiponectin receptors, in skeletal muscle of Type 2 diabetic
patients. Diabetologia. 47:917–925. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tsuchida A, Yamauchi T, Ito Y, et al:
Insulin/Foxo1 pathway regulates expression levels of adiponectin
receptors and adipo-nectin sensitivity. J Biol Chem.
279:30817–30822. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cui XB, Wang C, Li L, et al: Insulin
decreases myocardial adipo-nectin receptor 1 expression via
PI3K/Akt and FoxO1 pathway. Cardiovasc Res. 93:69–78. 2012.
View Article : Google Scholar
|
|
19
|
Fang X, Palanivel R, Zhou X, et al:
Hyperglycemia- and hyperinsulinemia-induced alteration of
adiponectin receptor expression and adiponectin effects in L6
myoblasts. J Mol Endocrinol. 35:465–476. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Uesugi A, Kozaki K, Tsuruta T, et al: The
tumor suppressive microRNA miR-218 targets the mTOR component
Rictor and inhibits AKT phosphorylation in oral cancer. Cancer Res.
71:5765–5778. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mathew LK, Skuli N, Mucaj V, et al:
mir-218 opposes a critical RTK-HIF pathway in mesenchymal
glioblastoma. Proc Natl Acad Sci USA. 111:291–296. 2014. View Article : Google Scholar :
|
|
22
|
Venkataraman S, Birks DK, Balakrishnan I,
et al: MicroRNA 218 acts as a tumor suppressor by targeting
multiple cancer phenotype-associated genes in medulloblastoma. J
Biol Chem. 288:1918–1928. 2013. View Article : Google Scholar :
|
|
23
|
Hassan MQ, Maeda Y, Taipaleenmaki H, et
al: mir-218 directs a wnt signaling circuit to promote
differentiation of osteoblasts and osteomimicry of metastatic
cancer cells. J Biol Chem. 287:42084–42092. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang WB, Zhong WJ and Wang L: A
signal-amplification circuit between miR-218 and Wnt/beta-catenin
signal promotes human adipose tissue-derived stem cells osteogenic
differentiation. Bone. 58:59–66. 2014. View Article : Google Scholar
|
